MeiraGTx Holdings plc(MGTX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #500 of 2,962 stocksTOP 25%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
MGTX Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for MeiraGTx Holdings plc (MGTX), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MGTX at 65.1/100 on a 32-signal composite quality model, placing it at rank #500 of 2,962 stocks — the top 25% of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), MeiraGTx Holdings plc reports quarterly revenue of $321.4M, net income of $160.7M, free cash flow of $-38.9M. Top institutional holders of MGTX by reported 13-F value include Sanofi, PERCEPTIVE ADVISORS, Rubric Capital Management, based on the most recent SEC filings. MGTX trades on the Nasdaq exchange and files with the SEC under CIK 1735438. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MGTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MeiraGTx Holdings plc directly from SEC EDGAR. MeiraGTx Holdings plc's 13F Pro composite quality score has ranged between 22 and 65 since 2026, currently 65.1 — an improving long-term trajectory across 48 quarterly and live scoring snapshots.
Revenue
Q2 2026
$321.4M
Net Income
Q2 2026
$160.7M
Free Cash Flow
Q2 2026
$-38.9M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+144.6% YoYNet Income
+22.7% YoYOperating Income
+35.5% YoYEPS (Diluted)
+33.0% YoYTotal Assets
-9.4% YoYOp. Cash Flow
+55.6% YoYFree Cash Flow
+54.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $81.4M +144.6% | $33.3M +137.4% | $14.0M -12.0% | $15.9M -57.8% | $37.7M +142.2% | $15.6M |
| Net Income | $-114.2M +22.7% | $-147.8M -75.9% | $-84.0M +35.2% | $-129.6M -62.9% | $-79.6M -37.2% | $-58.0M |
| Operating Income | $-106.0M +35.5% | $-164.2M -19.8% | $-137.1M -17.8% | $-116.4M -59.9% | $-72.8M -16.3% | $-62.6M |
| EPS (Diluted) | $-1.42 +33.0% | $-2.12 -42.3% | $-1.49 +48.1% | $-2.87 -59.4% | $-1.80 -16.9% | $-1.54 |
| Total Assets | $244.4M -9.4% | $269.8M -17.4% | $326.7M +2.7% | $318.2M -0.6% | $320.2M -12.0% | $363.7M |
| Operating Cash Flow | $-46.4M +55.6% | $-104.5M +0.8% | $-105.4M -44.1% | $-73.1M -594.2% | $-10.5M +83.5% | $-64.0M |
| Free Cash Flow | $-50.2M +54.1% | $-109.5M +12.8% | $-125.5M -6.3% | $-118.1M -107.6% | $-56.9M +33.0% | $-84.9M |
Get alerted when MGTX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for MeiraGTx Holdings plc including:
Top Institutional Holders of MGTX
Sanofi
$164.8M12,197,737 shPERCEPTIVE ADVISORS LLC
$145.7M10,786,658 shRubric Capital Management LP
$122.9M9,100,000 shJOHNSON & JOHNSON
$89.7M6,641,064 shBlackRock, Inc.
$64.3M4,757,178 shADAGE CAPITAL PARTNERS GP, L.L.C.
$59.4M4,400,000 shOpaleye Management Inc.
$48.0M3,550,000 shMILLENNIUM MANAGEMENT LLC
$40.1M2,971,752 sh683 Capital Management, LLC
$31.1M2,300,000 shWoodline Partners LP
$20.3M1,500,135 sh
| Fund | Value | Shares |
|---|---|---|
| Sanofi | $164.8M | 12,197,737 |
| PERCEPTIVE ADVISORS LLC | $145.7M | 10,786,658 |
| Rubric Capital Management LP | $122.9M | 9,100,000 |
| JOHNSON & JOHNSON | $89.7M | 6,641,064 |
| BlackRock, Inc. | $64.3M | 4,757,178 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $59.4M | 4,400,000 |
| Opaleye Management Inc. | $48.0M | 3,550,000 |
| MILLENNIUM MANAGEMENT LLC | $40.1M | 2,971,752 |
| 683 Capital Management, LLC | $31.1M | 2,300,000 |
| Woodline Partners LP | $20.3M | 1,500,135 |
Companies Similar to MGTX
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Arcutis Biotherapeutics, Inc.
ADMA BIOLOGICS, INC.
ZEVRA THERAPEUTICS, INC.
Eton Pharmaceuticals, Inc.
ALNYLAM PHARMACEUTICALS, INC.
SANUWAVE Health, Inc.
Caris Life Sciences, Inc.
BIOLIFE SOLUTIONS INC
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put MGTX on your watchlist
Track score changes the day MeiraGTx Holdings plc files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MGTX a good stock to buy?
13F Pro's AI-powered analysis of MeiraGTx Holdings plc (MGTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MGTX are available on the MGTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. MGTX is classified as a small company.
Which hedge funds own MGTX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MGTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MeiraGTx Holdings plc's investment landscape.